Long-term survival of patients with CML: The role of hematologic and cytogenetic response.

被引：0
|
作者：
Hasford, J [1 ]
Pfirrman, M [1 ]
Shepherd, P [1 ]
Guilhot, F [1 ]
Hehlmann, R [1 ]
Baccarani, M [1 ]
Mahon, FX [1 ]
Kluin-Nelemans, HC [1 ]
Ohnishi, K [1 ]
Steegmann, JL [1 ]
Thaler, J [1 ]
Delannoy, A [1 ]
Kloke, O [1 ]
机构：
[1] Univ Munich, IBE, Dept Biometry & Epidemiol, D-80539 Munich, Germany
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3102
引用
收藏
页码：785A / 785A
页数：1
相关论文
共 50 条
  • [1] Emerging marrow fibrosis is an early indicator of imatinib failure and shortened survival time in CML independent of hematologic, cytogenetic and molecular response.
    Buesche, G
    Hehlmann, R
    Ganser, A
    Hecker, H
    Freund, M
    Heimpel, H
    Heinze, B
    Gadzicki, D
    Schlegelberger, B
    Fonatsch, C
    Frye, B
    Tobler, A
    Georgii, A
    Kreipe, HH
    BLOOD, 2005, 106 (11) : 322A - 322A
  • [2] Imatinib gives impressive long-term survival in CML patients
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (02) : 71 - 71
  • [3] Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
    B Hanfstein
    M C Müller
    R Hehlmann
    P Erben
    M Lauseker
    A Fabarius
    S Schnittger
    C Haferlach
    G Göhring
    U Proetel
    H-J Kolb
    S W Krause
    W-K Hofmann
    J Schubert
    H Einsele
    J Dengler
    M Hänel
    C Falge
    L Kanz
    A Neubauer
    M Kneba
    F Stegelmann
    M Pfreundschuh
    C F Waller
    S Branford
    T P Hughes
    K Spiekermann
    G M Baerlocher
    M Pfirrmann
    J Hasford
    S Saußele
    A Hochhaus
    Leukemia, 2012, 26 : 2096 - 2102
  • [4] Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
    Hanfstein, B.
    Mueller, M. C.
    Hehlmann, R.
    Erben, P.
    Lauseker, M.
    Fabarius, A.
    Schnittger, S.
    Haferlach, C.
    Goehring, G.
    Proetel, U.
    Kolb, H-J
    Krause, S. W.
    Hofmann, W-K
    Schubert, J.
    Einsele, H.
    Dengler, J.
    Haenel, M.
    Falge, C.
    Kanz, L.
    Neubauer, A.
    Kneba, M.
    Stegelmann, F.
    Pfreundschuh, M.
    Waller, C. F.
    Branford, S.
    Hughes, T. P.
    Spiekermann, K.
    Baerlocher, G. M.
    Pfirrmann, M.
    Hasford, J.
    Saussele, S.
    Hochhaus, A.
    LEUKEMIA, 2012, 26 (09) : 2096 - 2102
  • [5] PMOS DOSIMETERS: LONG-TERM ANNEALING AND NEUTRON RESPONSE.
    Blamires, N.G.
    Totterdell, D.H.J.
    Holmes-Siedle, A.G.
    Adams, L.
    IEEE Transactions on Nuclear Science, 1986, NS-33 (06)
  • [6] Reply: The long-term response to imatinib treatment of CML
    F Michor
    British Journal of Cancer, 2007, 96 : 679 - 680
  • [7] Reply: The long-term response to imatinib treatment of CML
    Michor, F.
    BRITISH JOURNAL OF CANCER, 2007, 96 (04) : 679 - 680
  • [8] Effects of long-term treatment with TKI on incidence, prevalence and overall survival in CML patients
    Saussele, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 176 - 176
  • [9] Impact of Additional Cytogenetic Alterations At Diagnosis on Prognosis of CML: Long-Term Observation From 1151 Patients of the Randomized CML Study IV
    Fabarius, Alice
    Leitner, Armin
    Hochhaus, Andreas
    Mueller, Martin C.
    Haferlach, Claudia
    Goehring, Gudrun
    Schlegelberger, Brigitte
    Jotterand, Martine
    Reiter, Andreas
    Jung-Munkwitz, Susanne
    Proetel, Ulrike
    Schwaab, Juliana
    Hofmann, Wolf-Karsten
    Schubert, Joerg E. A.
    Einsele, Hermann
    Ho, Anthony D.
    Falge, Christiane
    Kanz, Lothar
    Neubauer, Andreas
    Kneba, Michael
    Stegelmann, Frank
    Pfreundschuh, Michael
    Waller, Cornelius F.
    Hiddemann, Wolfgang
    Baerlocher, Gabriela M.
    Lauseker, Michael
    Pfirrmann, Markus
    Saussele, Susanne
    Hehlmann, Ruediger
    Hasford, Joerg
    BLOOD, 2011, 118 (21) : 355 - 355
  • [10] Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV
    Fabarius, Alice
    Leitner, Armin
    Hochhaus, Andreas
    Mueller, Martin C.
    Hanfstein, Benjamin
    Haferlach, Claudia
    Goehring, Gudrun
    Schlegelberger, Brigitte
    Jotterand, Martine
    Reiter, Andreas
    Jung-Munkwitz, Susanne
    Proetel, Ulrike
    Schwaab, Juliana
    Hofmann, Wolf-Karsten
    Schubert, Joerg
    Einsele, Hermann
    Ho, Anthony D.
    Falge, Christiane
    Kanz, Lothar
    Neubauer, Andreas
    Kneba, Michael
    Stegelmann, Frank
    Pfreundschuh, Michael
    Waller, Cornelius F.
    Spiekermann, Karsten
    Baerlocher, Gabriela M.
    Lauseker, Michael
    Pfirrmann, Markus
    Hasford, Joerg
    Saussele, Susanne
    Hehlmann, Ruediger
    BLOOD, 2011, 118 (26) : 6760 - 6768
12345